Lupin Audit Report 2024 Lexus. Lupin ltd adr (lupny) q3 2024 earnings conference call february 8, 2024 5:30 am et. The s&p global sustainability yearbook 2024, a benchmark for corporate sustainability performance, evaluated over 9400 companies worldwide, with only 739.
The inspection was conducted at lupin’s global pharmacovigilance group based out of mumbai from march 20 to march 24, 2023. Along with its target price, nomura also raised its eps estimates for lupin.
Please Note That This Conference Is Being Recorded.
Pharmaceutical company lupin is likely to report a 7 per cent growth in revenue to rs.
January 02, 2024 / 09:59 Am Ist.
Audited standalone and consolidated financial results for the quarter and year ended march 31 2024.
The Analysts Expect The Pharma Company's Quarterly Revenue To Grow 16.4 Per Cent To Rs 5,156 Crore.
Images References :
Pharma Major Lupin Limited [Bse:
Lupin’s consolidated revenues for the financial year 2023 stood at ₹16,641 crore compared to ₹16,405 crore in fy22, with a net profit of ₹430 crore in fy23.
India Formulation Sales For Fy 2024 Were Inr 66,564 Mn, Up 9.6% As Compared To Inr 60,759 Mn In Fy2023;
Along with its target price, nomura also raised its eps estimates for lupin.
